Clinical Trials Logo

Social Phobia clinical trials

View clinical trials related to Social Phobia.

Filter by:

NCT ID: NCT03709615 Completed - Clinical trials for Social Anxiety Disorder

Therapeutic Processes in iCBT for SAD

Start date: December 20, 2017
Phase: N/A
Study type: Interventional

The current study examines therapeutic processes during internet-based cognitive-behavioral therapy for social anxiety disorder. Participants will be randomized to either treatment or wait-list conditions. Participants in the wait-list condition will receive active treatment following the wait-list period.

NCT ID: NCT03647605 Completed - Social Phobia Clinical Trials

Pilot Study: VR Mind and VR Mind+ Intervention

Start date: September 13, 2018
Phase: N/A
Study type: Interventional

The aim of the pilot study is feasibility, usability and safety assessment of VR Mind intervention. In particular the subject of assessment will be: - the length of the laboratory session utilizing virtual reality exposure (feasibility), - the ergonomics and ease of use for both patients and system operators (usability), - the frequency of side effect occurrence as a result of virtual reality exposure (ie. Vertigo) (safety). The results pilot study will be used in the designing a clinical trial aimed for testing efficacy and safety of VR Mind intervention.

NCT ID: NCT03514225 Completed - Clinical trials for Social Anxiety Disorder

Metacognitive Therapy for Social Anxiety in Youth

Start date: August 10, 2018
Phase: N/A
Study type: Interventional

Social anxiety disorder (SAD) is a fear of social situations that involve interacting with other people. Although it can be very upsetting, there are ways to help people deal with it. This study aims to explore the use of a new treatment called Metacognitive Therapy (MCT) for social anxiety in children and teenagers. MCT is a one-to-one talking therapy which works by changing people's patterns of attention and thinking in social situations. By doing this, people with SAD can begin to feel more confident and less anxious when interacting with others. Findings suggests that MCT works well when treating adults who have social anxiety. However, this treatment has not yet been used with young people. This study hopes to explore whether MCT can help treat SAD in children and teenagers. This information will help us to plan larger studies in the future. People who would like to take part in this study will be asked to fill in some questionnaires once a week for at least 2 weeks and return these to the researcher in the post. Following this, they will be offered 8 weekly sessions of MCT at their local Child and Adolescent Mental Health Service. Each session will last for about 1 hour. This will involve talking to a clinician about how they think and feel when in social situations, and filling in some more questionnaires. This will allow us to see how their social anxiety changes week-by-week and whether this has improved by the end of treatment (week 8). 1-months after people have had their last session of MCT, they will be asked to complete and return a final set of questionnaires through the post. This will allow us to get a final measure of their social anxiety and see whether any changes in SAD have been maintained. Primary Questions: - Is MCT a feasible and acceptable treatment for social anxiety disorder within a child and adolescent population? - Is MCT associated with improvements in SAD symptoms and functioning? Secondary Questions: - Are benefits associated with MCT replicable across subtypes of social anxiety disorder (general and specific)? - Are any gains associated with MCT for social anxiety disorder maintained at 1 month follow up?

NCT ID: NCT03507114 Recruiting - Depression Clinical Trials

Rumination Focus Cognitive Behavior Therapy

iRFCBT
Start date: March 27, 2018
Phase: N/A
Study type: Interventional

1. To investigate the efficacy and acceptability of a guided internet-delivered transdiagnostic intervention targeting repetitive negative thinking for individuals with elevated levels of depression and generalized anxiety disorder (mild to moderate clinical symptoms) vs a wait-list control group (WLCG). 2. To investigate the hypothesized mechanism of change: Repetitive negative thinking is reduced first, and consequently the clinical symptoms (depression and/or anxiety) decrease.

NCT ID: NCT03498599 Recruiting - Anxiety Disorders Clinical Trials

Neuroimaging of Pavlovian Fear Conditioning Processes in Patients With Pathological Anxiety

Start date: August 1, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to use functional magnetic resonance imaging to investigate how the human brain learns to form associations between neutral and emotional stimuli. The study is based on the basic principles of Pavlovian conditioning. When someone learns that a neutral stimulus (such as the sound of a bell) predicts an unpleasant stimulus (such as a mild electrical shock), the neutral stimulus takes on the properties of an emotional stimulus. The investigators are interested in the neural processes involved in this learning in people with a clinical anxiety disorder and posttraumatic stress disorder (PTSD).

NCT ID: NCT03275337 Completed - Anxiety Disorders Clinical Trials

Cerebellar Neuromodulation to Enhance Fear Extinction and Predict Response to Exposure Therapy

Start date: August 1, 2017
Phase: N/A
Study type: Interventional

Emerging neuroimaging studies have shown that the cerebellum contributes to different aspects of timing, prediction, learning, and extinction of conditioned responses to aversive stimuli, factors that may be relevant to the success of exposure based behavioral therapy. Our goals are to determine the cerebellar contributions to fear extinction by attempting to modulate key pathways in this process by theta burst stimulation. The long term goal is to lay the foundation for future studies in which neuromodulation is used to augment exposure therapy.

NCT ID: NCT03241277 Not yet recruiting - Clinical trials for Periodontal Diseases

Nonsurgical Periodontal Treatment in Patients With Social Phobia

NSPTSP
Start date: October 5, 2017
Phase: N/A
Study type: Interventional

Objective: To investigate the impact of nonsurgical periodontal treatment in patients with social anxiety disorder (SAD) and controls without phobia.

NCT ID: NCT03113175 Completed - Clinical trials for Post Traumatic Stress Disorder

Collabri Flex - Effect of Collaborative Care for People With Anxiety Disorders in General Practice

Start date: January 15, 2018
Phase: N/A
Study type: Interventional

The aim of the study Collabri Flex is to: - Develop a Danish model for collaborative care for patients with anxiety in general practice, based on past experience gained in the Collabri Project. - Examine the impact of this model compared with liaison-consultation for people with anxiety in a randomized controlled design from selected endpoints.

NCT ID: NCT03001154 Completed - Anxiety Clinical Trials

Virtual Reality Exposure Therapy for Speech Anxiety Using Commercial Hardware and Software

VRETORIK
Start date: January 1, 2017
Phase: N/A
Study type: Interventional

Virtual Reality Exposure Therapy (VRET) is an efficacious treatment of fear and anxiety, but because of the high financial costs and technical complexity of the past generation of VR hardware, there has been no large-scale implementation of this promising treatment. The present study will investigate whether off-the-shelf, commercial VR hardware and software can be used as stimuli material to conduct in-session exposure therapy for speech anxiety. The study will recruit n=25+25 participants from the general public suffering from substantial speech anxiety, who will be randomized to either a waiting-list, or one-session VRET with a therapist, followed by four weeks of a progressive maintenance program encouraging in-vivo exposure. The waiting-list group will then receive an Internet-delivered VRET treatment program.

NCT ID: NCT02926352 Completed - Social Phobia Clinical Trials

Effects of Low-Level Laser Stimulation With and Without Fear Extinction Training

Start date: August 1, 2015
Phase: Phase 1/Phase 2
Study type: Interventional

There are two specific aims for this study. Aim 1 is to test whether low-level laser therapy (LLLT) can enhance the efficacy of fear extinction training in the modification of pathological fear. Aim 2 is to investigate the efficacy of low-level laser therapy (LLLT) as a stand-alone intervention for anxiety/phobias.